To understand their feasibility as biomarkers for early detection and survival prediction of non-small cell lung cancer (NSCLC), we analyzed methylation statuses of SLIT1, SLIT2 and SLIT3 genes using the Infinium HumanMethylation450 BeadChip in 136 bronchial washings, 6 bronchial biopsies, 12 sputums, and 42 lung tumor and matched normal tissues. This evidence concerns the gene SLIT1 and non-small cell lung carcinoma.